Menon D K, Summors A C
Department of Anaesthesiology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK.
Curr Opin Anaesthesiol. 1998 Oct;11(5):485-96. doi: 10.1097/00001503-199810000-00006.
There have been over 2000 publications in the last year addressing the topic of neuroprotection. Novel and emerging therapeutic targets that have been explored include cerebral inflammation, hypothermia, neural transplantation and repair and gene therapy. Unfortunately, with few exceptions, the successes of experimental neuroprotection have not been translated into clinical practice. The possible reasons for the discrepancy between experimental success and clinical benefit are explored.
去年有超过2000篇关于神经保护主题的出版物。已探索的新型和新兴治疗靶点包括脑炎症、低温、神经移植与修复以及基因治疗。不幸的是,除了少数例外,实验性神经保护的成功并未转化为临床实践。本文探讨了实验成功与临床获益之间存在差异的可能原因。